Arena Pharmaceuticals, Inc.

Press Releases



All Releases

View Summary Arena Pharmaceuticals to Host First Quarter 2015 Financial Results Conference Call and Webcast on Monday, May 11
May 7, 2015
PDF 12.1 KB Add to Briefcase
View Summary Arena Pharmaceuticals Reports Favorable Results from Phase 1 Single-Ascending Dose Clinical Trial of APD371
Apr 29, 2015
PDF 12.4 KB Add to Briefcase
View Summary Eisai and Arena Pharmaceuticals Complete Registrational Trials of an Extended Release Formulation of Lorcaserin
Apr 10, 2015
PDF 20.7 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the Annual Needham Healthcare Conference
Apr 9, 2015
PDF 11.6 KB Add to Briefcase
View Summary Arena Pharmaceuticals Receives Additional Patent for BELVIQ® (lorcaserin HCl) from United States Patent and Trademark Office
Apr 7, 2015
PDF 20.6 KB Add to Briefcase
View Summary Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2014 Financial Results
Mar 2, 2015
PDF 26.2 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2014 Financial Results Conference Call and Webcast on Monday, March 2
Feb 23, 2015
PDF 12.6 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the 2015 RBC Capital Markets Healthcare Conference
Feb 18, 2015
PDF 11.7 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces Marketing Approval in South Korea of BELVIQ® (lorcaserin HCl) for Weight Management
Feb 3, 2015
PDF 14.0 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the 17th Annual BIO CEO & Investor Conference
Feb 2, 2015
PDF 11.7 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces Agreement to Sell Common Stock
Jan 21, 2015
PDF 13.1 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces Public Offering of Common Stock
Jan 20, 2015
PDF 12.4 KB Add to Briefcase
View Summary Arena Pharmaceuticals Initiates Phase 2 Clinical Trial Evaluating Ralinepag for Pulmonary Arterial Hypertension
Jan 12, 2015
PDF 13.5 KB Add to Briefcase
View Summary Arena Pharmaceuticals Reports on Eisai's New Marketing Initiatives for BELVIQ® (lorcaserin HCl) CIV
Jan 9, 2015
PDF 18.0 KB Add to Briefcase
View Summary Arena Pharmaceuticals Reports Positive Results from Phase 1b Clinical Trial Evaluating APD334 for the Treatment of Autoimmune Diseases
Jan 7, 2015
PDF 13.9 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Jan 6, 2015
PDF 11.7 KB Add to Briefcase
View Summary Arena Pharmaceuticals Issued Composition of Matter Patent by United States Patent and Trademark Office for Ralinepag and Related Compounds
Nov 25, 2014
PDF 13.9 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference
Nov 24, 2014
PDF 10.5 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at Stifel 2014 Healthcare Conference
Nov 13, 2014
PDF 10.5 KB Add to Briefcase
View Summary Lorcaserin HCl Data to be Presented at the Annual Meeting of the American Association for the Study of Liver Diseases
Nov 6, 2014
PDF 18.1 KB Add to Briefcase
Showing 41-60 of 526 Page: 1 2 3 4 5 6 7 ... 27  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase